Physician profile
Christopher A Potts
NPI 1750556023
$48,130.24
in general payments reported to CMS, 2019-2025
18 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,815 · 2020: $8,549 · 2021: $12K · 2022: $18K · 2023: $6,121 · 2024: $347 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,313 · Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,312.50 |
| Food and Beverage | $1,273.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $41,749.09 | 2019-2025 | Mako, Insignia, Omega |
| Smith+Nephew, INC. | $1,436.08 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Coblation, Bone Anchors With Arthroscopic Delivery System |
| Rti Surgical, INC | $1,429.32 | 2020-2021 | |
| Horizon Therapeutics Plc | $1,111.12 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $598.94 | 2019-2021 | |
| Surgalign Spine Technologies, INC. | $464.12 | 2019-2020 | |
| United Orthopedics LLC | $277.05 | 2023 | |
| Flower Orthopedics Coporation | $235.72 | 2020 | |
| Arthrosurface Incorporated | $182.35 | 2019-2020 | |
| Embody, INC. | $172.55 | 2022 | |
| Abbott Laboratories | $131.68 | 2021 | |
| Ferring Pharmaceuticals INC. | $119.02 | 2019-2023 | Euflexxa |
| Ermi LLC | $71.05 | 2023-2024 | |
| Vericel Corporation | $53.27 | 2019-2025 | Maci |
| Bioventus LLC | $47.41 | 2023 | Exogen Ultrasound Bone Healing System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $20.06 | 2019 | |
| Atland Pharmaceuticals, LLC | $15.83 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Depuy Synthes Sales INC. | $15.58 | 2023 | Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Potts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.